The last stage of a startup in its business plan is its
exit. This is when the company has done all it can and has identified that
to properly exploit the opportunity a major change in execution has to
happen. This exit from startup is typically done by either an entry in to
public company world through an IPO, or combining forces with others
through some form of Merger or Acquisition.
This is more thru with medical device startups than others.
Due to high cost of clinical studies and/or product commercialization, most
medical device companies identify their exit in an acquisition.
There are classes of medical products, especially those that
sell directly to consumers, or hospital systems, that have less demand on
capital. These companies can raise the funds needed to establish their
distribution channels thru an IPO.
Emerging Medical Solutions can help companies identify their
exit options and select the one that best match their strategic intent. Emerging
Medical Solutions can also facilitate execution of the exit strategy
selected by the company by providing access to the potential partners and
IPO service providers.
